Naringenin alleviates bone cancer pain via NF-κB/uPA/PAR2 pathway in mice.

Naringenin alleviated pain sensitization and bone damage of mice with BCP via TNF-α-mediated NF-κB/uPA/PAR2 pathway. We demonstrated a novel pathway for anti-BCP treatment with naringenin.